Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
07/2005
07/28/2005US20050163725 Method for administration of growth hormone via pulmonary delivery
07/28/2005US20050163723 Synthesis of small particles
07/28/2005US20050163710 Gastrin receptor-avid peptide conjugates
07/28/2005US20050163709 Development of DNA probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes
07/28/2005US20050163708 Chimeric antibody with specificity to human B cell surface antigen
07/28/2005DE202005001888U1 Antitumor composition comprises interleukin-2 and sodium dodecyl sulfate in the form of microaggregates
07/28/2005DE10360456A1 Tumorantigene und deren Verwendung Tumor antigens and the use thereof
07/28/2005DE10360435A1 New antibiotic peptides, useful in treating or preventing a microbial or viral infections or in inactivating Gram-positive and -negative bacteria, protozoa, fungi and virus
07/28/2005DE10358077A1 Verfahren zur Erhöhung der Sensitivität von Tumorzellen A method for increasing the sensitivity of tumor cells
07/28/2005CA2554001A1 Epitope/peptide recognized by hla-a2402-restricted ep-cam-specific ctl and use of the same
07/28/2005CA2553790A1 Differentiation regulating agent containing gene regulating differentiation from stem cells into natural killer cells as effective ingredient
07/28/2005CA2553609A1 Methods and compositions for modulating a steroid receptor
07/28/2005CA2553377A1 Gene therapy for tumors using minus-strand rna viral vectors encoding immunostimaulatory cytokines
07/28/2005CA2553336A1 Integrase fusion proteins and their use with integrating gene therapy
07/28/2005CA2553325A1 Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion
07/28/2005CA2552982A1 Botulinum toxin for treating vascular disorders
07/28/2005CA2552947A1 Chimera botulinum toxin type e
07/28/2005CA2552889A1 Iron supplement and utilization of the same
07/28/2005CA2552707A1 A method of reducing serum proinsulin levels in type 2 diabetics
07/28/2005CA2552677A1 Controlled release cgrp delivery composition for cardiovascular and renal indications
07/28/2005CA2552002A1 Azabenzofuran substituted thioureas as inhibitors of viral replication
07/28/2005CA2551879A1 Use of interleukin-21 for the treatment of autoimune diseases and allograft rejection
07/28/2005CA2551082A1 Hiv gp41 hr2-derived synthetic peptides, and their use in therapy to inhibit transmission of human immunodeficiency virus
07/28/2005CA2550625A1 Nutrient compositions and methods for enhanced effectiveness of the immune system
07/28/2005CA2547511A1 Recombinant icosahedral virus like particle production in pseudomonads
07/28/2005CA2546319A1 Production of glucagon like peptide 2 and analogs
07/28/2005CA2514395A1 Methods and compositions for the inhibition of cathepsins
07/27/2005EP1557466A1 Tumor antigen protein and utilization thereof
07/27/2005EP1557465A1 Cap-binding protein
07/27/2005EP1557432A2 Hybrid proteins which form heterodimers
07/27/2005EP1557428A1 Antibodies against a human stromal derived factor (SDF) and pharmaceutical composition containing them
07/27/2005EP1557427A2 Hedgehog protein conjugate
07/27/2005EP1557425A2 123 human secreted proteins
07/27/2005EP1557178A1 Use of sglt homolog
07/27/2005EP1557176A1 Treatment of bone metastases by means of PTH receptor agonists
07/27/2005EP1557175A1 Remedy for bone metabolic diseases
07/27/2005EP1557174A1 Composition containing eosinophil cationic protein
07/27/2005EP1557173A1 Soluble CTLA4 mutant molecules and uses thereof
07/27/2005EP1557172A1 Method and composition for regulating the activity of regulatory t cells
07/27/2005EP1556518A2 Genes and polypeptides relating to human pancreatic cancers
07/27/2005EP1556509A2 Antisense modulation of vegf co-regulated chemokine-1 expression
07/27/2005EP1556504A2 Protozoan rhomboid proteins
07/27/2005EP1556494A2 Bicistronic vector encoding a vegf and an fgf, use thereof
07/27/2005EP1556492A2 Antifreeze proteins isolated from forage grasses and methods for their use
07/27/2005EP1556490A2 Novel nucleic acids and polypeptides
07/27/2005EP1556489A1 Pharmaceutical composition for preparing a medicine for treating and/or preventing a pathology related to an obsessive behaviour or obesity
07/27/2005EP1556413A1 Methods and compositions for the treatment of ischemic reperfusion
07/27/2005EP1556411A2 Viral vectors and the use of the same for gene therapy
07/27/2005EP1556410A2 Peptide fragments of the harp factor inhibiting angiogenesis
07/27/2005EP1556402A2 In vivo gene silencing by chemically modified and stable sirna
07/27/2005EP1556401A2 22 human secreted proteins
07/27/2005EP1556399A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
07/27/2005EP1556362A2 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
07/27/2005EP1556141A1 Method for the prophylaxis and therapy of mycoses in fish and invertebrates and the development stages thereof
07/27/2005EP1556089A2 Inhibition of gene expression using rna interfering agents
07/27/2005EP1556084A2 Methods of regulating body weight
07/27/2005EP1556081A2 Recombinant intracellular pathogen immunogenic compositions and methods for use
07/27/2005EP1556080A1 Use of convertase inhibitors in the treatment of fibrosis and scarring
07/27/2005EP1556079A2 Regulatory protein for nox enzymes
07/27/2005EP1556078A1 Methods for treating lung cancer using insulin-like growth factorbinding protein-3
07/27/2005EP1556077A2 Use of cpg oligonucleotides in the treatment of hepatitis c virus infection
07/27/2005EP1556076A2 Apo-2 ligand/trail variants and uses thereof
07/27/2005EP1556075A2 Compositions for the treatment of autoimmune disorders
07/27/2005EP1556074A2 Casein derived peptides and uses thereof in therapy
07/27/2005EP1556073A2 Method and composition for preventing and treating solid tumors
07/27/2005EP1556071A2 Methods to prevent tumor recurrence by blockade of tgf-beta
07/27/2005EP1556070A2 Delocalization molecules and use thereof
07/27/2005EP1556069A2 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors
07/27/2005EP1556068A2 Treatment of autism and similar disorders
07/27/2005EP1556067A2 Phenolic binding peptides
07/27/2005EP1556066A2 Compositions and methods of use for a fibroblast growth factor
07/27/2005EP1556065A1 Method for isolating subpopulations of proteins that engage in protein-protein interactions
07/27/2005EP1556057A2 Agents and methods for enhancing bone formation
07/27/2005EP1556035A2 Novel aromatic compounds possessing antifungal or antibacterial activity
07/27/2005EP1556033A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
07/27/2005EP1556027A1 Modified amino acid for the inhibition of platelet aggregation
07/27/2005EP1556020A2 Use of cgrp antagonist compounds for treatment of psoriasis
07/27/2005EP1556004A2 Pharmaceutical compositions for buccal delivery of pain relief medications
07/27/2005EP1556003A2 Methods of administering and enhancing absorption of pharmaceutical agents
07/27/2005EP1556001A2 Therapeutic compositions for drug delivery to and through covering epithelia
07/27/2005EP1501922A4 Methods of modulating heme oxygenase-1 expression and treating heme oxygenase-1 mediated conditions
07/27/2005EP1324764B1 Method for inducing onset of the reproductive cycle of female breeding animals
07/27/2005EP1320295A4 Collagen/polysaccharide bilayer matrix
07/27/2005EP1289559B1 Combinations of enzyme inhibitor-containing preparations and the use thereof
07/27/2005EP1214063B1 Treating cancer using tetraethyl thiuram disulfide
07/27/2005EP1206539B1 Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds
07/27/2005EP1077716B1 Preparation of a medicament for the treatment of gastroesophageal reflux disease
07/27/2005EP1053018B1 DELIVERY OF IMMUNOGENIC MOLECULES VIA HBsAg PARTICLES
07/27/2005EP1025236B1 Human checkpoint kinase, hcds1, compositions and methods
07/27/2005EP0990000B1 Connective tissue growth factor-3
07/27/2005EP0977848B1 Human theta subunit of the gaba-a receptor
07/27/2005EP0952855B1 Use of hyaluronan in gene therapy
07/27/2005EP0831888B1 Methods for increasing hematopoietic cells
07/27/2005EP0799051B1 Irrigation solution and use thereof for perioperatively inhibiting pain, inflammation and spasm at a wound
07/27/2005EP0682707B1 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion
07/27/2005CN2712931Y Electromagnetic cleavage device for cleavage extracting polypeptide from vegetable protein
07/27/2005CN1647506A 数码相机 Digital Camera
07/27/2005CN1646703A Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene
07/27/2005CN1646692A Genetic products differentially expressed in tumors and use thereof
07/27/2005CN1646689A Novel scavenger receptors
1 ... 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 1422 1423 1424 1425 1426 ... 3163